切换至 "中华医学电子期刊资源库"

中华肥胖与代谢病电子杂志 ›› 2023, Vol. 09 ›› Issue (01) : 28 -32. doi: 10.3877/cma.j.issn.2095-9605.2023.01.006

综述

减重手术在肥胖合并银屑病治疗中的研究进展
吴琼, 管蔚, 林士波, 梁辉, 许利剑()   
  1. 211300 南京,南京医科大学第二附属医院普外科
    210029 南京,南京医科大学第一附属医院普外科
  • 收稿日期:2022-09-26 出版日期:2023-02-28
  • 通信作者: 许利剑

Research progress of bariatric surgery in the treatment of obesity with psoriasis

Qiong Wu, Wei Guan, Shibo Lin, Hui Liang, Lijian Xu()   

  1. Department of General Surgery, the Second Affiliated Hospital of Nanjing Medical University, Nanjing 211300
    Department of General Surgery, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
  • Received:2022-09-26 Published:2023-02-28
  • Corresponding author: Lijian Xu
引用本文:

吴琼, 管蔚, 林士波, 梁辉, 许利剑. 减重手术在肥胖合并银屑病治疗中的研究进展[J]. 中华肥胖与代谢病电子杂志, 2023, 09(01): 28-32.

Qiong Wu, Wei Guan, Shibo Lin, Hui Liang, Lijian Xu. Research progress of bariatric surgery in the treatment of obesity with psoriasis[J]. Chinese Journal of Obesity and Metabolic Diseases(Electronic Edition), 2023, 09(01): 28-32.

银屑病是一种迁延难愈、并发症多、具有遗传背景的慢性免疫炎症性疾病。文献报道部分患有银屑病的肥胖患者,由于受到肥胖引起的代谢性疾病的困扰,接受了减重手术后,在体重下降、代谢症状改善的同时,银屑病亦得到了较好的缓解,减重手术可能改善银屑病的预后,具体表现为术后银屑病皮损缓解,银屑病治疗药物疗效增加,治疗药物级别下降,银屑病缓解后复发率低。本文就减重手术在肥胖合并银屑病治疗中的研究进展作一综述。

Psoriasis is a chronic immune inflammatory disease with protracted course, many complications and genetic background. It is reported in the literature that some patients with obesity who have psoriasis are troubled by metabolic diseases caused by obesity. After bariatric surgery, psoriasis has also been better alleviated while weight loss and metabolic symptoms have been improved. Bariatric surgery may improve the prognosis of psoriasis,specifically manifested as the relief of psoriasis skin lesions after surgery, the increase of therapeutic efficacy of psoriasis drugs, the decline of therapeutic drug level, and the low recurrence rate of psoriasis after remission. This article reviews the research progress of bariatric surgery in the treatment of obesity complicated with psoriasis.

[1]
Gómez R, Conde J, Scotece M, et al. What's new in our understanding of the role of adipokines in rheumatic diseases? [J]. Nat Rev Rheumatol, 2011, 7(9): 528-536.
[2]
Cao H. Adipocytokines in obesity and metabolic disease [J]. J Endocrinol, 2014, 220(2): 47-59.
[3]
Korman NJ. Management of psoriasis as a systemic disease: what is the evidence? [J]. Br J Dermatol, 2020, 182(4): 840-848.
[4]
李慧贤, 胡丽, 郑焱, 等. 基于全球疾病负担(GBD)大数据的中国银屑病流行病学负担分析 [J]. 中国皮肤性病学杂志, 2021, 35(4): 386-392.
[5]
Armstrong A W, Read C. Pathophysiology, Clinical presentation, and treatment of psoriasis: a review [J]. Jama, 2020, 323(19): 1945-1960.
[6]
中华医学会皮肤性病学分会, 中国医师协会皮肤科医师分会, 中国中西医结合学会皮肤性病专业委员会. 中国银屑病生物制剂治疗指南(2021) [J]. 中华皮肤科杂志, 2021, 54(12): 1033-1047.
[7]
Setty AR, Curhan G, Choi HK. Obesity, waist circumference, weight change, and the risk of psoriasis in women: Nurses' Health Study II [J]. Arch Intern Med, 2007, 167(15): 1670-1675.
[8]
Snekvik I, Smith CH, Nilsen TIL, et al. Obesity, waist circumference, weight change, and risk of incident psoriasis: prospective data from the HUNT study [J]. J Invest Dermatol, 2017, 137(12): 2484-2490.
[9]
Naldi L, Chatenoud L, Linder D, et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: results from an Italian case-control study [J]. J Invest Dermatol, 2005, 125(1): 61-67.
[10]
Debbaneh M, Millsop JW, Bhatia BK, et al. Diet and psoriasis, part I: Impact of weight loss interventions [J]. J Am Acad Dermatol, 2014, 71(1): 133-1340.
[11]
Lindegård B. Diseases associated with psoriasis in a general population of 159,200 middle-aged, urban, native Swedes [J]. Dermatologica, 1986, 172(6): 298-304.
[12]
Naldi L, Conti A, Cazzaniga S, et al. Diet and physical exercise in psoriasis: a randomized controlled trial [J]. Br J Dermatol, 2014, 170(3): 634-642.
[13]
Wollina U, Dreßler M, Lohmann T. Bariatric surgery - a dermatologic perspective [J]. J Eur Acad Dermatol Venereol, 2015, 29(5): 835-841.
[14]
Romero-Talamás H, Aminian A, Corcelles R, et al. Psoriasis improvement after bariatric surgery [J]. Surg Obes Relat Dis, 2014, 10(6): 1155-1159.
[15]
Ponce J, Demaria EJ, Nguyen NT, et al. American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in 2015 and surgeon workforce in the United States [J]. Surg Obes Relat Dis, 2016, 12(9): 1637-1639.
[16]
中国医师协会外科医师分会肥胖和糖尿病外科医师委员会. 中国肥胖代谢外科手术方式推荐立场声明 [J/CD]. 中华肥胖与代谢病电子杂志, 2021, 7(1): 8-12.
[17]
任庆贵, 张弘玮, 董维峰, 等. 胃旁路术和袖状胃切除术对重度肥胖患者疗效对比分析 [J]. 中华内分泌外科杂志, 2016, 10(06): 474-477.
[18]
Chen YY, Lan CCE. Improved therapeutic response to biologic treatment after bariatric surgery: Experience from an obese patient with psoriasis [J]. Dermatologica Sinica, 2020, 38(1): 51-54.
[19]
Khaitan M, Hegde A, Rekha PD. Bariatric Surgery in Immunocompromised Patients: Outcomes from One Year Follow-up [J]. Obes Surg, 2018, 28(9): 2811-2814.
[20]
Odorici G, Conti A. Psoriasis improvement after gastric bandage in a patient partial responder to infliximab [J]. Dermatol Ther, 2018, 31(2): 12584.
[21]
Babino G, Giunta A, Bianchi L, et al. Morbid obesity and psoriasis: Disease remission after laparoscopic sleeve gastrectomy [J]. Obes Res Clin Pract, 2017, 11(3): 370-372.
[22]
Egeberg A, Sørensen JA, Gislason GH, et al. Incidence and prognosis of psoriasis and psoriatic arthritis in patients undergoing bariatric surgery [J]. JAMA Surg, 2017, 152(4): 344-349.
[23]
Hossler EW, Wood GC, Still CD, et al. The effect of weight loss surgery on the severity of psoriasis [J]. Br J Dermatol, 2013, 168(3): 660-661.
[24]
Brüünsgaard H, Pedersen BK. Age-related inflammatory cytokines and disease [J]. Immunol Allergy Clin North Am, 2003, 23(1): 15-39.
[25]
Villarreal-Calderon JR, Cuellar-Tamez R, Castillo EC, et al. Metabolic shift precedes the resolution of inflammation in a cohort of patients undergoing bariatric and metabolic surgery [J]. Sci Rep, 2021, 11(1): 12127.
[26]
Maglio C, Peltonen M, Rudin A, et al. Bariatric surgery and the incidence of psoriasis and psoriatic arthritis in the swedish obese subjects study [J]. Obesity (Silver Spring), 2017, 25(12): 2068-2073.
[27]
Farias MM, Achurra P, Boza C, et al. Psoriasis following bariatric surgery: clinical evolution and impact on quality of life on 10 patients [J]. Obes Surg, 2012, 22(6): 877-880.
[28]
Pérez-Pérez L, Allegue F, Caeiro JL, et al. Severe psoriasis, morbid obesity and bariatric surgery [J]. Clin Exp Dermatol, 2009, 34(7): 421-422.
[29]
Laskowski M, Schiöler L, Ottosson J, et al. Impact of bariatric surgery on moderate to severe psoriasis: a retrospective nationwide registry study [J]. Acta Derm Venereol, 2021, 101(6): 00487.
[30]
Rachid B, Van De Sande-Lee S, Rodovalho S, et al. Distinct regulation of hypothalamic and brown/beige adipose tissue activities in human obesity [J]. Int J Obes (Lond), 2015, 39(10): 1515-1522.
[31]
Coimbra S, Catarino C, Santos-Silva A. The triad psoriasis-obesity-adipokine profile [J]. J Eur Acad Dermatol Venereol, 2016, 30(11): 1876-1885.
[32]
Kelly AS, Ryder JR, Marlatt KL, et al. Changes in inflammation, oxidative stress and adipokines following bariatric surgery among adolescents with severe obesity [J]. Int J Obes (Lond), 2016, 40(2): 275-280.
[33]
Viana EC, Araujo-Dasilio KL, Miguel GP, et al. Gastric bypass and sleeve gastrectomy: the same impact on IL-6 and TNF-α Prospective clinical trial [J]. Obes Surg, 2013, 23(8): 1252-1261.
[34]
Huang D, Zhang Z, Dong Z, et al. Caloric restriction and Roux-en-Y Gastric Bypass promote white adipose tissue browning in mice [J]. J Endocrinol Invest, 2022, 45(1): 139-148.
[35]
Briot K, Garnero P, Le Henanff A, et al. Body weight, body composition, and bone turnover changes in patients with spondyloarthropathy receiving anti-tumour necrosis factor {alpha} treatment [J]. Ann Rheum Dis, 2005, 64(8): 1137-1140.
[36]
刘宝军, 张海涛, 张铁铮. 全麻术后患者银屑病痊愈6例 [J]. 中国皮肤性病学杂志, 1996, 3: 185.
[37]
焦珂珺, 王雨晶, 曹征宇. 复方利多卡因乳膏对银屑病的治疗作用 [J]. 药学学报: 2023: 58(1): 1-15.
[1] 陈嘉婷, 杜美君, 石冰, 黄汉尧. 母体系统性疾病对新生儿唇腭裂发生的影响[J]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 262-268.
[2] 孟令凯, 李大勇, 王宁, 王桂明, 张炳南, 李若彤, 潘立峰. 袖状胃切除术对肥胖伴2型糖尿病大鼠的作用及机制研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(06): 638-642.
[3] 李猛, 姜腊, 董磊, 吴情, 贾犇黎. 腹腔镜胃袖状切除术治疗肥胖合并2型糖尿病及脂肪胰的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 554-557.
[4] 吉顺富, 汤晓燕, 徐进. 腹腔镜近端胃癌根治术中拓展胃后间隙在肥胖患者中的应用研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 393-396.
[5] 杨波, 胡旭, 何金艳, 谢铭. 腹腔镜袖状胃切除术管胃固定研究现状[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 452-455.
[6] 刘超凡, 王文越, 杨珵璨, 朱冬梓, 王兵. 胃袖状切除术上调循环Nrg4浓度抑制肝脏脂肪酸合成改善肥胖小鼠肝脏脂肪变性[J]. 中华普外科手术学杂志(电子版), 2024, 18(02): 133-136.
[7] 赵帅, 王伟, 李瑞奇, 周家杰, 王道荣. 3D腹腔镜下袖状胃切除术治疗肥胖合并2型糖尿病的临床疗效及影响因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(02): 146-149.
[8] 刘盾, 潘晟. 不同入路腹腔镜袖状胃切除术用于肥胖症合并2型糖尿病的效果[J]. 中华普外科手术学杂志(电子版), 2024, 18(02): 150-154.
[9] 唐小久, 胡曼, 许必君, 肖亚. 肥胖合并胃食管反流病患者严重程度与其焦虑抑郁及营养状态的相关性研究[J]. 中华消化病与影像杂志(电子版), 2024, 14(04): 360-364.
[10] 王星, 陈园, 热孜万古丽·乌斯曼, 郭艳英. T2DM、Obesity、NASH、PCOS共同致病因素相关的分子机制[J]. 中华临床医师杂志(电子版), 2024, 18(05): 481-490.
[11] 乔晓红, 薛晓峰, 查振刚, 蔡若莲, 牛建军, 任立新, 杨慧峰, 李雪梅, 郭秀珍. 骨关节炎患者血清中Vaspin的表达及其与关节病变严重程度的关系[J]. 中华临床医师杂志(电子版), 2024, 18(02): 152-158.
[12] 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国医师协会外科医师分会肥胖代谢外科综合管理专家工作组, 中国肥胖代谢外科研究协作组. 中国肥胖代谢外科数据库:2023年度报告[J]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 73-83.
[13] 颜宥彤, 赵锐, 万谦益, 张贵祥, 沈弘毅, 程中, 陈亿. GLP-1受体激动剂——司美格鲁肽的应用及安全性[J]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 88-93.
[14] 杨宁琍, 梁辉. 中国肥胖代谢外科个案管理教育培训现状及展望[J]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 94-99.
[15] 周彪, 李政奇, 孟化. 肥胖与内镜下减重治疗研究进展[J]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 100-107.
阅读次数
全文


摘要